Insider · CIK 0001627183
Patrick O'Brien
cooofficer
Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). First filing Jan 7, 2025, latest Jan 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $3.9M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARWR: ARROWHEAD PHARMACEUTICALS, INC.
ARWROct 9, 2026 · close 62.75
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ARROWHEAD PHARMACEUTICALS, INC. | $3.1M 49,493 shares | -9% | +539% from low-10% from high | |
| 36Weak | ARROWHEAD PHARMACEUTICALS, INC. | $736k 37,184 shares | -7% | +10% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 7, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 8,000 0.01% of outstanding | $158k | Jan 7, 2025 | $578k |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 29,184 0.02% of outstanding | $578k | Jan 6, 2025 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock | -540 | $0.00 | $0 | 474,368 | Jan 8, 2026 |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock | -540 | $0.00 | $0 | 473,828 | Jan 8, 2026 |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock | -540 | $0.00 | $0 | 473,288 | Jan 8, 2026 |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock | -440 | $0.00 | $0 | 472,848 | Jan 8, 2026 |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock | -440 | $0.00 | $0 | 472,408 | Jan 8, 2026 |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 547,408 | Jan 8, 2026 |
| Dec 31, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -560 | $0.00 | $0 | 526,641 | Jan 5, 2026 |
| Dec 31, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -560 | $0.00 | $0 | 526,081 | Jan 5, 2026 |
| Dec 31, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -560 | $0.00 | $0 | 525,521 | Jan 5, 2026 |
| Dec 31, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -560 | $0.00 | $0 | 524,961 | Jan 5, 2026 |
| Dec 31, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | GGift Common Stock10b5-1 | -560 | $0.00 | $0 | 524,401 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,368 | $61.20 | $267k | 520,033 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,164 | $62.23 | $384k | 513,869 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -13,451 | $62.96 | $847k | 500,418 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -11,842 | $63.84 | $756k | 488,576 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,700 | $64.44 | $174k | 485,876 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -900 | $66.01 | $59k | 484,976 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -313 | $68.00 | $21k | 484,663 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -600 | $61.12 | $37k | 484,063 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -900 | $62.25 | $56k | 483,163 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,873 | $62.91 | $369k | 477,290 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,336 | $64.04 | $150k | 474,954 | Jan 5, 2026 |
| Jan 5, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -46 | $68.00 | $3,128 | 474,908 | Jan 5, 2026 |
| Jan 4, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +100,000 | $0.00 | $0 | 564,385 | Jan 7, 2025 |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -19,658 | $19.69 | $387k | 544,727 | Jan 7, 2025 |
| Jan 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -9,526 | $20.10 | $191k | 535,201 | Jan 7, 2025 |
| Jan 7, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8,000 | $19.69 | $158k | 527,201 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.